More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
Adobe Class Action
Data Breach and Privacy, Existing Cases
On April 3, 2025, Lowey filed a data privacy class action against Adobe, Inc. alleging it used consumers’ personally identifiable information and online activity to create user profiles without obtaining […]
UCSF Class Action
Data Breach and Privacy, Existing Cases
In Doe v. The Regents of the University of California, No. 3:23-cv-00598 (N.D. Cal.), Lowey Dannenberg represents a class of individuals who used the University of California San Francisco Medical […]
News
Lowey Dannenberg and Co-Counsel File Class Action on Behalf of End-Payors for Immunosuppressive Drug Stelara (Ustekinumab)
On December 7, 2023, Lowey Dannenberg, P.C. and its co-counsel, representing named Plaintiff CareFirst BlueCross BlueShield,filed suit against Stelara manufacturer Johnson & Johnson (“J&J”) in the U.S. District Court for the Eastern District of Virginia. The…
Blog
SEC Investigations, Climate Risk Disclosures & Impact on Corporate Governance
On Monday, March 21, 2021, the Securities Exchange Commission released a 510-page proposal that would require U.S.-listed companies to provide certain climate-related information in their registration statements and annual reports. This long-anticipated draft rule coupled with increased investor...

